Raloxifene [orch, phsu]
cardiovascular events [fndg]
postmenopausal [tmco]
Women [popg]
Four [qnco]
Result [ftcn]
More [ftcn]
Multiple [qnco]
Outcome [ftcn]
Raloxifene [orch, phsu]
Evaluation [ftcn]
randomized [resa]
Trial [resa]
Context [fndg]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
cardiovascular risk factor [dsyn]
Effect [qlco]
cardiovascular events [fndg]
Unknown [qlco]
Objective [inpr]
Effect [qlco]
Raloxifene [orch, phsu]
cardiovascular events [fndg]
postmenopausal [tmco]
Women [popg]
Design [acty]
secondary [neop]
Analysis [lbpr]
Data [idcn]
Multiple [qnco]
Outcome [ftcn]
Raloxifene [orch, phsu]
Evaluation [ftcn]
Trial [resa]
randomized controlled trial [inpr, resa]
DOUBLE BLIND [resa]
placebo [topp]
Conduct [inbe]
setting [ftcn]
Out-patient [podg]
Community [geoa]
setting [ftcn]
Sites [spco]
Countries [geoa]
participants [popg]
postmenopausal [tmco]
Women [popg]
Mean [qnco]
Age [orga]
intervention [hlca]
Patients [podg]
Assigned [ftcn]
To [qlco]
Receive [qlco]
Raloxifene [orch, phsu]
mg/d [qnco]
mg/d [qnco]
placebo [topp]
N NOS [aapp, imft]
Main [qlco]
Outcome [ftcn]
Measure [qnco]
cardiovascular events [fndg]
Including [ftcn]
coronary [bpoc]
Events [evnt]
Myocardial Infarction [dsyn]
Angina, Unstable [dsyn]
coronary [bpoc]
Ischaemia [dsyn]
Cerebrovascular [qlco]
Events [evnt]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Collected [idcn]
Safety [hcpp]
End Point [qlco]
Cardiologist [prog]
Blinded [resa]
therapy [ftcn]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Study [mnob]
Entry [inpr]
Presence [topp]
Multiple [qnco]
cardiovascular risk factor [dsyn]
Prior [tmco]
coronary [bpoc]
Events [evnt]
Revascularisation [topp]
Procedure [diap, topp]
Result [ftcn]
Overall [inpr]
Cohort [popg]
treatment [ftcn]
Group [idcn]
Combined [qlco]
coronary [bpoc]
Cerebrovascular [qlco]
Events [evnt]
placebo [topp]
mg/d [qnco]
Raloxifene [orch, phsu]
mg/d [qnco]
Raloxifene [orch, phsu]
Risks, Relative [qnco]
Confidence Interval [qnco]
Confidence Interval [qnco]
mg/d [qnco]
mg/d [qnco]
Raloxifene [orch, phsu]
Similar [qlco]
Result [ftcn]
Obtained [ftcn]
coronary [bpoc]
Cerebrovascular [qlco]
Events [evnt]
Analyzed [resa]
Subset [clas]
Women [popg]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
baseline [bodm]
Assigned [ftcn]
Raloxifene [orch, phsu]
Low Risk [fndg]
cardiovascular events [fndg]
Compared [acty]
placebo [topp]
Confidence Interval [qnco]
Raloxifene [orch, phsu]
Group [idcn]
cardiovascular events [fndg]
First [qnco]
Not [ftcn]
Different [qlco]
Group [idcn]
Overall [inpr]
Cohort [popg]
P NOS [aapp, imft]
Women [popg]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
P NOS [aapp, imft]
Evidence [ftcn]
Established [qlco]
coronary heart disease [dsyn]
P NOS [aapp, imft]
Conclusions [idcn]
Raloxifene [orch, phsu]
therapy [ftcn]
Not [ftcn]
Affect [menp]
Risk [qlco]
cardiovascular events [fndg]
Overall [inpr]
Cohort [popg]
Risk [qlco]
cardiovascular events [fndg]
Subset [clas]
Women [popg]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Evidence [ftcn]
Raloxifene [orch, phsu]
Early [tmco]
Increase [ftcn]
Risk [qlco]
cardiovascular events [fndg]
Raloxifene [orch, phsu]
Prevention [topp]
cardiovascular events [fndg]
findings [ftcn]
confirmation [qlco]
Trial [resa]
Evaluation [ftcn]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Primary [qlco]
Objective [inpr]
